Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alloimmune thrombocytopenias.

Abdulgabar Salama1

  • 1Charité, Institut für Transfusionsmedizin, Augustenburger Platz 1, 13353 Berlin, Germany. abdulgabar.salama@charite.de

Journal of Pediatric Hematology/Oncology
|December 12, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal metabolomics study of phosphate-adenine-guanosine-glucose-saline-mannitol stored red blood cells.

Transfusion·2026
Same author

Ex vivo Drug Metabolism Using Primary Human Hepatocytes for the Detection of Metabolite-Dependent Antibodies to Red Blood Cells.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2025
Same author

Polyclonal Anti-D Antibodies Significantly Reduce the Rate of Miscarriages in Rh(D) positive Women with Recurrent Pregnancy loss.

Obstetrics and gynecology research·2023
Same author

Silvernanoparticle-induced hemolysis confounded with direct antiglobulin test-negative autoimmune hemolytic anemias diagnosis.

Transfusion·2022
Same author

Safety of Uncrossmatched ABO-Compatible RBCs in Alloimmunized Patients with Bleeding: Data from Two Decades: Results of a Systematic Analysis in 6,109 Patients.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2022
Same author

A fluorometric erythrophagocytosis assay using differentiated monocytic THP-1 cells to assess the clinical significance of antibodies to red blood cells.

Vox sanguinis·2021
Same journal

Increased 18F-FDG Avidity on PET/CT During Treatment for Rhabdomyosarcoma Confirmed to Be Mature Rhabdomyoblasts.

Journal of pediatric hematology/oncology·2026
Same journal

Assessment of Immunization Status Following Non-HSCT Chemotherapy-treated Pediatric Leukemia Survivors.

Journal of pediatric hematology/oncology·2026
Same journal

Frequent Use of Hematologic Testing in Children Admitted for Nonaccidental Trauma.

Journal of pediatric hematology/oncology·2026
Same journal

Unresponsive Systemic Mastocytosis in a Young AML With RUNX1::RUNX1T1 Fusion With Rare KIT c.1255_1257delGAC Mutation: A Clinical Deadlock.

Journal of pediatric hematology/oncology·2026
Same journal

Local Control and Survival Outcomes in Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcoma: The Mayo Clinic Experience.

Journal of pediatric hematology/oncology·2026
Same journal

Diagnostic Pitfalls in Pediatric Acute Promyelocytic Leukemia: All-trans Retinoic Acid-Associated Hypercalcemia Mimicking Fungal Meningitis and the Risks of Azole Coadministration.

Journal of pediatric hematology/oncology·2026
See all related articles

Alloimmunization against platelet antigens can occur during pregnancy or after transfusions, leading to various alloimmune thrombocytopenias. Neonatal alloimmune thrombocytopenia is the most common type in children, with compatible platelet transfusions being the fastest treatment post-delivery.

Area of Science:

  • Immunology
  • Hematology
  • Obstetrics

Background:

  • Alloimmunization to platelet antigens is a significant clinical issue.
  • It can arise from pregnancy, blood transfusions, or transplantation.
  • Antibody formation leads to rapid destruction of incompatible platelets.

Purpose of the Study:

  • To classify and describe different types of alloimmune thrombocytopenias.
  • To highlight the incidence and importance of neonatal alloimmune thrombocytopenia.
  • To discuss current management and treatment strategies.

Main Methods:

  • Literature review and synthesis of existing data on alloimmune thrombocytopenias.
  • Classification of alloimmune thrombocytopenias based on clinical presentation and etiology.

Related Experiment Videos

  • Summary of diagnostic and therapeutic approaches.

    • Main Results:

    • Alloimmune thrombocytopenias include neonatal alloimmune thrombocytopenia, post-transfusion purpura, passive alloimmune thrombocytopenia, transplantation-associated alloimmune thrombocytopenia, and platelet transfusion refractoriness.
    • Neonatal alloimmune thrombocytopenia affects approximately 1 in 1,000 births, being the primary concern in pediatric cases.
    • Management during pregnancy remains undefined, but compatible platelet transfusion is effective post-delivery.

    Conclusions:

    • Alloimmune thrombocytopenias represent a spectrum of conditions caused by immune responses to platelet antigens.
    • Neonatal alloimmune thrombocytopenia is a critical condition in newborns requiring prompt treatment.
    • Further research is needed for prenatal management strategies, while postnatal care focuses on compatible platelet support.